Aimei Health Technology (AFJK) Stock Price, News & Analysis

Company Overview

Aimei Health Technology Co., Ltd does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or similar business combination with one or more businesses or entities. The company was incorporated in 2023 and is based in New York, New York.

Key Stats

• Today's Range: $10.48 to $10.55
• 50-Day Range: $10.36 to $10.48
• 52-Week Range: $10.15 to $10.55
• Volume: 20,125 shs
• Average Volume: 56,166 shs
• Market Capitalization: $94.59 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

AFJK Stock Analysis - Frequently Asked Questions

How have AFJK shares performed this year?

Aimei Health Technology's stock was trading at $10.16 at the beginning of the year. Since then, AFJK stock has increased by 3.1% and is now trading at $10.48.
View the best growth stocks for 2024 here.

Who are Aimei Health Technology's major shareholders?

Aimei Health Technology's top institutional investors include Glazer Capital LLC (6.52%), Wolverine Asset Management LLC (5.49%), Shaolin Capital Management LLC (4.43%) and Cowen AND Company LLC (0.78%).

How do I buy shares of Aimei Health Technology?

Shares of AFJK stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Company Calendar

• Today: 9/18/2024
• Fiscal Year End: 12/31/2024

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Unclassified
• Industry: Holding & other investment offices
• Sub-Industry: Trading
• Current Symbol: NASDAQ:AFJK
• CUSIP: N/A
• CIK: 1979005
• Web: N/A
• Phone: 34-67-803-5200
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 1.83
• Quick Ratio: 1.83

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: $0.02 per share
• Price / Cash Flow: 480.24
• Book Value: ($0.02) per share
• Price / Book: -524.00

Miscellaneous

• Outstanding Shares: 9,026,000
• Free Float: N/A
• Market Cap: $94.59 million
• Optionable: N/A
• Beta: N/A